Beth Ann Drolet, MD

Chief experience officer, Children's Hospital of Wisconsin
Medical director, Birthmarks and Vascular Anomalies, Children's Hospital of Wisconsin
Professor, the Medical College of Wisconsin

Office locations

8915 W. Connell Ct.
Milwaukee, WI 53226
(414) 266-6430
(877) 607-5280 (appointment)
1655 W Mequon Rd
Mequon, WI 53092


Dr. Drolet is a board certified dermatologist, and a fellowship trained pediatric dermatologist. She has a special interest in birthmarks and infantile hemangiomas. Dr. Drolet has created a collaborative research team to improve management of infants with hemangiomas and vascular anomalies. Her team has led several national initiatives to better define high risk vascular lesions and determine the best and safest treatment plans for these conditions. In 2004, she established the Birthmarks and Vascular Anomalies Center at CHW. This novel interdisciplinary team includes nine pediatric specialties which provide comprehensive care for patients with complex, multi-system vascular anomalies. This center has attained national recognition with greater than 50% of patients traveling from outside Southeastern Wisconsin. Dr. Drolet is a strong advocate for patients and families; she is committed to provide compassionate, timely, care for children with skin disease and to develop an innovative research center that will bring new knowledge and ultimately provide more effective care for her patients. 

Pediatric Dermatology, Dermatology
Areas of interest
  • Dermatology
  • Infantile hemangiomas
  • Vascular birthmarks
  • Laser surgery
  • Birthmarks

Education and awards

  • 1991, Loyola Univ of Chicago-Stritch School of Med, MD
  • 1995, Medical College of Wisconsin - Dermatology
  • 1997, Medical College of Wisconsin - Ped Dermatology
  • Best Doctors in America
  • Milwaukee Top Doctors
  • Rare Disease Science Challenge: Be HEARD Award, 2012
  • Esterly Traveling Lectureship Award, Society for Pediatric Dermatology, 2013

Research and publications

  • Genetic Mosaicism in Linear Morphea, Society for Pediatric Dermatology William Weston Award, Co-Investigator/Mentor.
  • Incidence of Hypoglycemia in Children Receiving Propranolol Therapy for Infantile Hemangiomas, Society for Pediatric Dermatology Award, Mentor.
  • Pediatric Dermatology Research Alliance Annual Conference, NIH R13, Co-Investigator.
  • Evaluation of Endothelial Progenitor Cells and Hypoxia-induced Mediators of EPC Trafficking in Patients with Infantile Hemangiomas, Co-Investigator Dermatology Foundation Award
  • Long-Term Outcomes of Vascular Anomalies, Co-PI
  • Phenotypic Features of PHACE Syndrome, Co-Investigator
  • Longitudinal; Study of Neurologic, Cognitive, and Radiologic Outcomes in PHACE syndrome, Principal Investigator Greater Milwaukee Foundation, Blaser Foundation
  • A Single Center Study to Determine the Incidence of Hypoglycemia in Children with Infantile Hemangioma Receiving Propranolol Therapy, Principal Investigator/Mentor Society for Pediatric Dermatology Weston Research Award
  • International Registry for Vascular Anomalies Associated with Coagulopathy, Principal Investigator
  • Influence of Demographic Factors in Those Affected by Birthmarks, Principal Investigator
  • Clinical and Genetic Analysis of Genetic Skin Disorders, Co-Investigator
  • Genetic Analysis of PHACE Syndrome, Co-Investigator
  • Genetic Basis of Hemangiomas, Principal Investigator